We demonstrated for the first time that ADAM32 plays a crucial role in HBL via regulation of cancer cell proliferation, stemness, migration, invasion, and acquired resistance to therapy via an extrinsic apoptotic signal. This evidence concerns the gene ADAM32 and cancer.